医学
托珠单抗
类风湿性关节炎
荟萃分析
随机对照试验
托法替尼
内科学
作者
Alisson Pugliesi,Daniela Oliveira,Vani Abreu de Souza Filho,Júlia de Oliveira Machado,Aline Gonçalves Pereira,Júlia de Castro Silveira Bichuette,Zoraida Sachetto,Luiz Sérgio Fernandes de Carvalho,Manoel Barros Bértolo
标识
DOI:10.1016/j.semarthrit.2024.152563
摘要
We aimed to compare the risk of major adverse cardiovascular events (MACE) and all-cause of death (ACD) in patients with rheumatoid arthritis (RA) treated with JAK inhibitors (JAKi) or tocilizumab (TCZ) versus tumor necrosis factor (TNF) inhibitors (TNFi).
科研通智能强力驱动
Strongly Powered by AbleSci AI